Zobrazeno 1 - 10
of 1 110
pro vyhledávání: '"Chronic myeloproliferative disorders"'
Publikováno v:
Journal of Scientific Innovation in Medicine, Vol 3, Iss 3 (2020)
Externí odkaz:
https://doaj.org/article/fcb7a8c634d248a89dd627dffd92eab0
Publikováno v:
Avicenna Journal of Medicine, Vol 07, Iss 01, Pp 28-31 (2017)
Objective: We aimed to investigate the frequency of Janus kinase 2 ( JAK2) mutations in cases with chronic myeloproliferative disorders (CMDs), and the relationship between the presence of JAK2 mutation and leukocytosis and splenomegaly, retrospectiv
Externí odkaz:
https://doaj.org/article/a157274e74a74057940a257df7922f66
Autor:
Nikolayenko-Kamyshova T.P.
Publikováno v:
Medičnì Perspektivi, Vol 20, Iss 3, Pp 144-147 (2015)
Disturbances in the system of he¬mostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm. Thrombus-hemorrhagic complications in patients with chronic m
Externí odkaz:
https://doaj.org/article/84fa3462e0124a4aa670be092be74e56
Autor:
Fusun Gediz Ozdemirkiran, Sinem Nalbantoglu, Zafer Gokgoz, Bahriye Kadriye Payzin, Filiz Vural, Seckin Cagirgan, Afig Berdeli
Publikováno v:
Archives of Medical Science, Vol 13, Iss 2, Pp 426-432 (2016)
Introduction : Chronic myeloproliferative disorders (CMPD) are chronic myeloid hematological disorders, characterized by increased myeloid cell proliferation and fibrosis. Impaired apoptotic mechanisms, increased cell proliferation, uncontrolled hema
Externí odkaz:
https://doaj.org/article/92485c5aafcd4c8b9624ea414266ae23
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
T. P. Nikolayenko-Kamyshova
Publikováno v:
Medičnì Perspektivi, Vol 20, Iss 3, Pp 144-147 (2015)
Disturbances in the system of hemostasis and vascular complications is the topical clinical problem, requiring profound study with the development of treatment and prophylaxis algorithm. Thrombus-hemorrhagic complications in patients with chronic m
Externí odkaz:
https://doaj.org/article/ac5c2e0039fb4eb2ad2d08f8982866c2
Autor:
Alicia Rovó, Claudia Baierlein-Leimbach, Cesare Medri, Ioannis Chanias, Loreen Errass, Theresa Fehr, Therese Triemer, Daphne B. McCarthy-Pontier, Thomas Lehmann
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 14; Pages: 4234
Rovó, Alicia; Baierlein-Leimbach, Claudia; Medri, Cesare; Chanias, Ioannis; Errass, Loreen; Fehr, Theresa; Triemer, Therese; McCarthy-Pontier, Daphne B; Lehmann, Thomas (2022). Hematocrit Self-Testing in Patients with Polycythemia Vera and Other Hematological Conditions: Assessing the Accuracy of the StatStrip Xpress® 2 LAC/Hb/Hct Device and User Opinion about the Device in Real-World Clinical Practice. Journal of clinical medicine, 11(14) MDPI 10.3390/jcm11144234
Rovó, Alicia; Baierlein-Leimbach, Claudia; Medri, Cesare; Chanias, Ioannis; Errass, Loreen; Fehr, Theresa; Triemer, Therese; McCarthy-Pontier, Daphne B; Lehmann, Thomas (2022). Hematocrit Self-Testing in Patients with Polycythemia Vera and Other Hematological Conditions: Assessing the Accuracy of the StatStrip Xpress® 2 LAC/Hb/Hct Device and User Opinion about the Device in Real-World Clinical Practice. Journal of clinical medicine, 11(14) MDPI 10.3390/jcm11144234
Maintaining hematocrit (Hct) levels below 45% can reduce morbidity and mortality in patients with polycythemia vera (PV). A device that patients can use to self-monitor Hct levels could enable timely interventions if Hct levels increase above 45%, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b080a40fa471e0eeb8287accfaa3afd1
Autor:
Zsófia Adravetz, Előd Papp, András Komócsi, Miklós Egyed, Réka Faludi, Gyöngyvér Költő, Margit Tőkés-Füzesi
Publikováno v:
Archives of Medical Science : AMS
IntroductionPrecapillary pulmonary hypertension (PH) implies a worse prognosis in myeloproliferative neoplasms (MPN). N-terminal pro-B-type natriuretic peptide (NT-proBNP) is elevated in cardiopulmonary involvement. In MPN patients with precapillary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56446bcf3f400e02885305268547e1e1
http://europepmc.org/articles/PMC8641504
http://europepmc.org/articles/PMC8641504
Autor:
Nur Soyer, Ali Şahin Küçükarslan, Fahri Şahin, Demet Çekdemir, Buket Kosova, Zuhal Eroğlu, Mahmut Töbü, Murat Tombuloğlu, Seçkin Çağırgan, Ayhan Dönmez, Filiz Vural, Güray Saydam
Publikováno v:
Turkish Journal of Hematology, Vol 28, Iss 04, Pp 306-311 (2011)
Objective: The aim of this study was to examine Factor V G1691A (Leiden) (FVL) and prothrombin G20210A (PT) gene mutation status, and their relationship with thrombosis in patients with chronic myeloproliferative disorders (CMPDs).Materials and Metho
Externí odkaz:
https://doaj.org/article/0a8d762e00fb433cbfdd2ab4c6f18622
Autor:
Nur Soyer, Ali Şahin Küçükarslan, Fahri Şahin, Demet Çekdemir, Buket Kosova, Zuhal Eroğlu, Mahmut Töbü, Murat Tombuloğlu, Seçkin Çağırgan, Ayhan Dönmez, Filiz Vural, Güray Saydam
Publikováno v:
Turkish Journal of Hematology, Vol 28, Iss 4, Pp 306-311 (2011)
OBJECTIVE: The aim of this study was to examine Factor V G1691A (Leiden) (FVL) and prothrombin G20210A (PT) gene mutation status, and their relationship with thrombosis in patients with chronic myeloproliferative disorders (CMPDs). METHODS: The study
Externí odkaz:
https://doaj.org/article/5739f62d8e974d6b82824144c1a9288a